LeeLemonoil
Member
- Joined
- Sep 24, 2016
- Messages
- 4,265
Interesting Preprint @haidut
Read also how mainstream science seems to finally adopt in a way Peat‘s stance about „receptors“ - now they just write that proteins like StaR are „both receptors“ and Membrane components that can take up all kinds of things -
Anyway Vitamin A and derivates are not surprisingly involved in how a Cov-infection plays out, it’s a crucial endocrine and immune Modulator and even facilitates epigenetic rapid changes
Although, the ACE2 receptor has been demonstrated to be the main entry receptor of COVID-19, but our docking analysis , predicted and discovered a novel receptor termed STRA6 that may play a critical role in the pathogenicity of COVID-19 and explain the common pre and post COVID-19 symptoms with unknown etiology. STRA6 receptor expressed in many organs and immune cells, upregulated by retinoic acid jm6 (STRA6) was the first protein to be identified in a novel category of proteins, cytokine signaling transporters, due to its ability to function as both a cell surface receptor and a membrane protein that binds to retinol binding protein facilitating cellular uptake of retinol. The primary ligand of STRA6 (vitamin/retinol) was shown to be drastically reduced during COVID-19 infection, which agrees with our findings
Read also how mainstream science seems to finally adopt in a way Peat‘s stance about „receptors“ - now they just write that proteins like StaR are „both receptors“ and Membrane components that can take up all kinds of things -
Anyway Vitamin A and derivates are not surprisingly involved in how a Cov-infection plays out, it’s a crucial endocrine and immune Modulator and even facilitates epigenetic rapid changes
STRA6 (vitamin A receptor), as a Novel binding receptor of COVID-19 (A breakthrough)
BackgroundA global pandemic of pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, China, at the end of 2019. Although, the ACE2 receptor has been demonstrated to be the main entry receptor of COVID-19, but our dock...
www.researchsquare.com
Although, the ACE2 receptor has been demonstrated to be the main entry receptor of COVID-19, but our docking analysis , predicted and discovered a novel receptor termed STRA6 that may play a critical role in the pathogenicity of COVID-19 and explain the common pre and post COVID-19 symptoms with unknown etiology. STRA6 receptor expressed in many organs and immune cells, upregulated by retinoic acid jm6 (STRA6) was the first protein to be identified in a novel category of proteins, cytokine signaling transporters, due to its ability to function as both a cell surface receptor and a membrane protein that binds to retinol binding protein facilitating cellular uptake of retinol. The primary ligand of STRA6 (vitamin/retinol) was shown to be drastically reduced during COVID-19 infection, which agrees with our findings